We are live on
!
Find out more
WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$4.16B
1-Year Est. Return
30.77%
This Fund
S&P 500
This Quarter
Est. Return
+6.82%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$1.62B
AUM Growth
+$327M
(+25%)
Cap. Flow
+$276M
Cap. Flow
% of AUM
17.05%
Top 10 Holdings %
Top 10 Hldgs %
13.6%
Holding
564
New
168
Increased
107
Reduced
129
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRE
Veris Residential
VRE
|
+$18M |
| 2 |
LPT
Liberty Property Trust
LPT
|
+$17.7M |
| 3 |
Extra Space Storage
EXR
|
+$17.5M |
| 4 |
Vornado Realty Trust
VNO
|
+$16.9M |
| 5 |
MPT
Medical Properties Trust
MPT
|
+$15.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GGP
GGP Inc.
GGP
|
+$29.8M |
| 2 |
SL Green Realty
SLG
|
+$25.5M |
| 3 |
HPP
Hudson Pacific Properties
HPP
|
+$21.9M |
| 4 |
PPS
Post Properties
PPS
|
+$18.3M |
| 5 |
CSX Corp
CSX
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 16.81% |
| 2 | Consumer Discretionary | 13.32% |
| 3 | Industrials | 8.52% |
| 4 | Energy | 8.46% |
| 5 | Healthcare | 5.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Pacira BioSciences
PCRX
$1.02B
| $305K | 0.02% |
+8,900
| New | +$349K |
|
|
MZOR
377
DELISTED
Mazor Robotics Ltd.
MZOR
| $298K | 0.02% |
11,500
-3,080
| -21% | -$68.3K |
|
|
OCRX
378
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $290K | 0.02% |
110,000
-2,995
| -3% | -$7.48K |
|
379
Builders FirstSource
BLDR
$7.84B
| $288K | 0.02% |
25,000
-1,286
| -5% | -$16.2K |
|
380
Novartis
NVS
$295B
| $276K | 0.02% |
3,906
-162
| -4% | -$11.8K |
|
381
Rigel Pharmaceuticals
RIGL
$680M
| $275K | 0.02% |
7,500
-10,725
| -59% | -$307K |
|
382
Enanta Pharmaceuticals
ENTA
$372M
| $266K | 0.02% |
+10,000
| New | +$232K |
|
383
CALL
Diana Shipping
DSX
$280M
| $262K | 0.02% |
+143,033
| New | +$262K |
|
384
Xenon Pharmaceuticals
XENE
$6.32B
| $255K | 0.02% |
31,500
-900
| -3% | -$6.95K |
|
|
SPNC
385
DELISTED
Spectranetics Corp
SPNC
| $251K | 0.02% |
10,000
-935
| -9% | -$21.8K |
|
|
IMMU
386
DELISTED
Immunomedics Inc
IMMU
| $250K | 0.02% |
77,000
+4,100
| +6% | +$11.5K |
|
|
INSY
387
DELISTED
Insys Therapeutics, Inc.
INSY
| $248K | 0.02% |
21,000
-510
| -2% | -$7.75K |
|
388
Standard BioTools
LAB
$326M
| $240K | 0.01% |
30,000
+8,130
| +37% | +$74.7K |
|
|
MACK
389
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $235K | 0.01% |
4,703
+533
| +13% | +$22.1K |
|
390
TG Therapeutics
TGTX
$8.58B
| $232K | 0.01% |
30,000
-600
| -2% | -$3.86K |
|
|
ITCI
391
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $229K | 0.01% |
15,000
-32,385
| -68% | -$1.31M |
|
392
Abbott
ABT
$180B
| $221K | 0.01% |
5,214
-2,314
| -31% | -$99.2K |
|
393
Cardiff Oncology
CRDF
$64.3M
| $220K | 0.01% |
681
-230
| -25% | -$83.8K |
|
|
AAWW
394
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $214K | 0.01% |
+5,000
| New | +$195K |
|
395
Molina Healthcare
MOH
$10.3B
| $211K | 0.01% |
3,622
-508
| -12% | -$28K |
|
396
TherapeuticsMD
TXMD
$23.8M
| $211K | 0.01% |
620
-7
| -1% | -$2.56K |
|
397
Planet Fitness
PLNT
$4.23B
| $201K | 0.01% |
+10,000
| New | +$206K |
|
398
Vanda Pharmaceuticals
VNDA
$312M
| $200K | 0.01% |
+12,000
| New | +$162K |
|
|
ANTH
399
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $184K | 0.01% |
7,313
-205
| -3% | -$5.17K |
|
|
TTOO
400
DELISTED
T2 Biosystems, Inc
TTOO
| $181K | 0.01% |
5
+2
| +67% | +$65.7K |
|
Similar funds
SS
PMEF
CC
GW
BC
GC
WP
BWM
Weiss Multi-Strategy Advisers's Q3 2016 Portfolio in Review
As of Q3 2016, Weiss Multi-Strategy Advisers held 564 positions worth $1.62B, up 25% from $1.29B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Weiss Multi-Strategy Advisers deployed $276M of net new capital in Q3 2016, opening 168 new positions and adding to 107 existing holdings. Its largest new stake was Veris Residential: 650,231 shares worth $17.7M.
By sector, the portfolio is most concentrated in Real Estate at 17% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was SL Green Realty, an estimated $25.5M trimmed.
- Weiss Multi-Strategy Advisers's largest Q3 2016 buy was Veris Residential: 650,231 shares worth $17.7M.
- Weiss Multi-Strategy Advisers added most to Parkway, Inc. in Q3 2016, an estimated $13.7M increase.
- Weiss Multi-Strategy Advisers's biggest Q3 2016 reduction was SL Green Realty, cutting an estimated $25.5M.
- Weiss Multi-Strategy Advisers fully exited GGP Inc. in Q3 2016, selling an estimated $29.8M.
- Weiss Multi-Strategy Advisers's ten largest holdings make up 14% of its $1.62B portfolio in Q3 2016.
- Weiss Multi-Strategy Advisers opened 168 new positions and closed 155 in Q3 2016.
- Weiss Multi-Strategy Advisers's portfolio value rose 25% quarter-over-quarter to $1.62B.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2016, filed 14 Nov 2016.